General Information
Revision date
2012-03-27
Product name
anti-Fractalkine Monoclonal Antibody
1.2.1 Relevant identified uses
Refer to the instruction 800.424.9300 booklet for proper and OUTSIDE US
supplier name
Thermo Fisher Scientific
Manufacturer Name
Thermo Fisher Scientific
Icons in SDS
Company Information
company name
Thermo Fisher Scientific
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Emergency overview Physical state » Liquid.
Hazard statements
NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED. OSHAIHCS status While this material is not considered hazardous by the
Potential Acute Health Effects
Inhalation No known significant effects or critical hazards, f i Ingestion No known significant ef fects or crit ical hazards, Skin + No known significant effects or cr ficant ef f i cal hazards, Eyes No known significant effects or critical hazards. ficant ef i ti Potential chroni¢ health effects
Potential chronic health
+ No known significant effects or critical hazards, f Carcinogenicity + No known significant effects or crit i ical hazards, Mutagenicity No known significant ef fects or cri ti ical hazards, Teratoyenicity + No known significant effects or crit f cal hazards, Developmental effects No known significant effects or cr ficant ef f i cal hazards, Fertility effects + No known significant effects or critical hazards, ficant ef i ti 272012, 7 Lie Scievce Researe 5 Box 177 Rocklerd IL (a5) 960074? eer lner no con Pierce Sioteshno ocy Ime S767 NL Meri ent Rage ai (815; 968-7316 Fa, anti-Fractalkine Monoclonal Antibody 2, Hazards identification Overexposure siqnsisymploms Inhalation No specific data, Skin No specific data, Ingestion No specific data, Eyes No specific data, Medical conditions » None known. aggravated hy over- exposure See toxicological information (Section 11}